ARCHIVES

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

This article is from The Cancer Letter archive.

Vol. 29 No. 46 | December 12, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

In Brief: Outstanding Investigator Awards Draw 150 Letters Of Intent; Applications Due July 15

June 15, 1984

Moddelmog Steps Down At Komen For the Cure

November 20, 2009

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

December 28, 2007

Mass. Requires Coverage of Routine Patient Care In Clinical Trials

September 6, 2002

Committee Drafts QRA Definition

November 19, 1982